Merritt Island Medical Research
Merritt Island Medical Research is a Florida-based clinical research site specializing in Alzheimer's disease and neurodegenerative disorder trials, operating as a location within the Flourish Research multi-state clinical research network. The site recruits patient volunteers and delivers sponsor-funded clinical trial conduct services to pharmaceutical and biotech clients.
- Company typePrivate
- Founded2015
- HeadquartersMerritt Island, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Merritt Island Medical Research does
Merritt Island Medical Research, now operating as Merritt Island Clinical Research, is a Florida-based clinical research site specializing in memory testing, consultation, and clinical trials for neurodegenerative disorders — with a particular focus on Alzheimer's disease. The site was founded in 2015 and operates as a location within the Flourish Research multi-state clinical research network, which spans 11+ U.S. states and is headquartered in Apex, North Carolina. The site recruits patients through a community-led go-to-market approach, employing physician referrals, community impact programs, social media, and a website-based study-search and scheduling portal to drive enrollment into active studies.
The site's core product is clinical trial conduct services delivered to pharmaceutical companies and research sponsors, generating revenue through study contracts that cover patient recruitment, study execution, and data collection. Beyond its Alzheimer's specialization, the site offers diagnostic testing services (ECGs, lab work, radiological tests, medical exams, genetic testing) at no cost to participants, in-patient and overnight research capabilities for continuous-monitoring studies, and demographic-specific trial programs covering men's, women's, pediatric, and senior populations. Participants receive monetary compensation for time and travel, and all services are provided free of charge to volunteers. The underlying technology is operational rather than proprietary — clinical research facility infrastructure, a website study portal, and standard digital scheduling — with no disclosed AI/ML components, patents, or proprietary software.
The business model is a professional services, sponsor-funded revenue model: pharmaceutical companies and research sponsors pay for clinical trial conduct, while patients serve as the recruited participants (not the paying customers). Customer segments are therefore two-sided — clinical trial volunteers (the recruited supply) and pharma/biotech sponsors (the monetized demand). The site positions domain specialization in Alzheimer's and neurodegenerative disorders, combined with membership in the Flourish Research network, as its primary competitive differentiators.
Merritt Island Medical Research firmographics
Firmographics- Name
- Merritt Island Medical Research
- Legal name
- Flourish Research
- Website
- https://mimresearch.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Merritt Island Medical Research is a Florida-based clinical research site specializing in Alzheimer's disease and neurodegenerative disorder trials, operating as a location within the Flourish Research multi-state clinical research network. The site recruits patient volunteers and delivers sponsor-funded clinical trial conduct services to pharmaceutical and biotech clients.
- Ownership category
- akta.pro rank
Merritt Island Medical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where Merritt Island Medical Research is headquartered
LocationHeadquarters
- HQ city
- Merritt Island
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Merritt Island Medical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales
Revenue model
- Clinical Trial Conduct Services: Conducts clinical trials on behalf of pharmaceutical companies and research sponsors. Revenue is generated through study contracts, where sponsors pay for research services including patient recruitment, study execution, and data collection.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Merritt Island Medical Research product offering
Product offeringCore offering
Merritt Island Medical Research operates a clinical research site that conducts Phase I–IV clinical trials, with a primary focus on neurodegenerative disorders such as Alzheimer's disease. The site offers diagnostic testing services and in-patient/overnight study capabilities for trial participants at no cost, while serving as a contracted research site for pharmaceutical sponsors and clinical research organizations.
Product overview
Merritt Island Medical Research, now operating as Merritt Island Clinical Research under Flourish Research, is a clinical research site offering a unified platform of clinical trial services. The organization specializes in neurodegenerative disorders research, particularly Alzheimer's disease, and provides diagnostic testing, in-patient services, and specialized trials for various demographics including men, women, pediatric, and senior populations. The product portfolio centers on clinical trial participation, diagnostic testing services, and overnight/in-patient research capabilities, all offered at no cost to participants with compensation for time and travel.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trials for Neurodegenerative Disorders
Companies that use Merritt Island Medical Research
Customer profileSegments5 records
Ideal customer profiles2 records
Merritt Island Medical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Merritt Island Medical Research partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Merritt Island Medical Research competitors and assessment
Company assessmentBroad incumbents
- Medpace: Mid-to-large CRO with therapeutic expertise across neuroscience, comparable as a broad incumbent competing for the same Alzheimer's and neurodegenerative trial sponsorships.
- IQVIA: Largest global CRO with site management operations including neuroscience, comparable as a buyer/competitor of site-level trial services and an indirect counterparty for sponsor contracts.
- Syneos Health: Large biopharmaceutical solutions organization with site network and CNS franchise, comparable as a broad incumbent providing end-to-end clinical development including site management.
- ICON plc: Global CRO with significant neuroscience and Alzheimer's trial experience, comparable as a broad incumbent offering site services, feasibility, and patient recruitment at scale.
- Fortrea (formerly Labcorp Drug Development): Large CRO offering clinical trial services across therapeutic areas including CNS, comparable as a broad incumbent that competes for the same sponsor relationships driving site revenue.
Direct peers
- Benchmark Research: Multi-site clinical research organization with therapeutic areas overlapping Merritt Island's portfolio, comparable in operating model as a Phase I–IV trial site serving pharmaceutical sponsors.
- Accel Research Sites: Multi-therapeutic clinical research site network operating across Florida with similar Phase I–III trial execution capabilities, directly comparable in site-model, geographic overlap, and sponsor-facing service mix.
- Compass Research: Florida-based clinical trial site network with similar therapeutic breadth including CNS and neurodegenerative studies, comparable patient-recruitment-driven GTM and sponsor contract model.
- CNS Healthcare: Specialty clinical research organization focused on central nervous system and neurodegenerative disorder trials, highly comparable in therapeutic focus (Alzheimer's/Parkinson's) and site-based patient recruitment.
- WCCT Global (Worldwide Clinical Trials Early Phase): Clinical trial site organization with in-patient and overnight study capabilities, directly comparable in offering extended-stay research services and a diversified therapeutic trial portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Merritt Island Medical Research social profiles
Digital presenceMerritt Island Medical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Merritt Island Medical Research leadership team
Management profileNumber of profiles
Merritt Island Medical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Merritt Island Medical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Merritt Island Medical Research
What does Merritt Island Medical Research do?
Merritt Island Medical Research operates a clinical research site that conducts Phase I–IV clinical trials, with a primary focus on neurodegenerative disorders such as Alzheimer's disease. The site offers diagnostic testing services and in-patient/overnight study capabilities for trial participants at no cost, while serving as a contracted research site for pharmaceutical sponsors and clinical research organizations.
Is Merritt Island Medical Research a public or private company?
Merritt Island Medical Research is a private company. It is classified as corporate owned and is currently operating.
When was Merritt Island Medical Research founded?
Merritt Island Medical Research was founded in 2015. It employs 11 to 50 people.
Where is Merritt Island Medical Research based?
Merritt Island Medical Research is headquartered in Merritt Island, United States, in the North America region.
How does Merritt Island Medical Research make money?
One revenue line is on record: clinical Trial Conduct Services.
Who are Merritt Island Medical Research's main competitors?
Broad incumbents on record are Medpace, IQVIA, Syneos Health, ICON plc and Fortrea (formerly Labcorp Drug Development). Direct peers are Benchmark Research, Accel Research Sites, Compass Research, CNS Healthcare and WCCT Global (Worldwide Clinical Trials Early Phase).
Does Merritt Island Medical Research have an API?
No public API is recorded for Merritt Island Medical Research.
What industry is Merritt Island Medical Research in?
Merritt Island Medical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 62151 and its SIC code is 8731.